Publications

  • Private equity groups under pressure to take ‘riskier’ bets

    March 04, 2018 | Private Equity | Financial Times | Media mention

    Buyout firms are pursuing large public companies at their fastest pace, with deals totaling $180 billion last year, according to Bain & Company. Graham Elton, a partner with Bain, said the big question troubling the industry is “when does the music stop”?

  • Consumer goods: big brands battle with the ‘little guys’

    February 27, 2018 | Consumer Products | Financial Times | Media mention

    According to Bain & Company, despite rising global demand, 34 of the world’s 50 biggest consumer companies are suffering either from slower sales and profits growth, or both. “Companies will need to fundamentally revisit their way of working and transform themselves,” says Matthew Meacham, a

  • Bain & Co: Still a way to go for UK retailers to modernize

    December 28, 2017 | Retail | CNBC | Media mention

    Anna Thal Larsen, a partner with Bain & Company, looks at how Brexit and Amazon.com has and could impact consumer confidence, when it comes to retail.

  • Banks lag in digital change, other countries may copy EU fintech rules: Bain

    November 24, 2017 | Banking | S&P Global Intelligence | Media mention

    "There is a level of self-inflicted pain that the banks are causing" themselves, said Eduardo Roma, a partner with Bain & Company.

  • Black Friday an extreme test of a retailer's digital capabilities: Bain & Company

    November 23, 2017 | Retail | CNBC | Media mention

    Anna Thal Larsen, partner at Bain & Company, speaks about retail sector trends as Black Friday looms.

  • Bain & Co.'s Rafael Natanek on how to make your drug launch a success

    September 27, 2017 | Pharmaceuticals | S&P Global | Media mention

    Following a survey of 100 executives at the top 20 pharmaceutical companies, Rafael Natanek, a partner with Bain & Company, talked to S&P Global Market Intelligence about the critical importance of a successful new drug launch, given that drug companies will derive 25% to 80% of their revenue from

  • UK film industry squeezed by subscription VOD giants digital onslaught

    September 26, 2017 | Telecommunications | S&P Global | Media mention

    Amazon, Netflix, HBO and a host of other less traditional content producers that are actively producing high-quality, original content in a range of genres, for audiences in the U.S. and internationally, have fueled "intense competition for stand-out, original programming," said Alex Bhak, a

  • European banking landscape increasingly polarized, says analyst

    September 06, 2017 | Banking | CNBC | Media mention

    Strong banks have been getting stronger but a number of banks could be in danger, João Soares, partner with Bain & Company, told CNBC.

  • Number of European lenders in danger rises sharply

    September 04, 2017 | Banking | Financial Times | Media mention

    A new report by Bain & Company shows that the number of European banks in grave danger rose sharply last year and is now close to its 2013 level, despite extensive efforts by lenders to bolster balance sheets and profits. "The fragile banks that have not acted effectively or that delayed taking

  • The construction industry: Least improved

    August 19, 2017 | Infrastructure, Construction & Building Products | The Economist | Media mention

    Volatility in demand for construction has trained builders to curb investment. "The industry has learned through bitter experience to prepare for the next recession," says Luc Luyten, a partner with Bain & Company.